CHoBI7: Cholera-Hospital-Based-Intervention-for-7-days

Sponsor
Johns Hopkins Bloomberg School of Public Health (Other)
Overall Status
Completed
CT.gov ID
NCT04008134
Collaborator
International Centre for Diarrhoeal Disease Research, Bangladesh (Other)
2,626
3
28.7

Study Details

Study Description

Brief Summary

The Cholera Hospital Based Intervention for 7 Days (CHoBI7) randomized controlled trial for transition to scale aimed to: (1) Develop and evaluate scalable approaches to integrate the CHoBI7 intervention into the services provided for hospitalized diarrhea patients at health facilities in Bangladesh; and (2) Evaluate the ability of the CHoBI7 intervention to lead to a sustained uptake of the promoted hand washing with soap and water treatment behaviors and significant reductions in diarrheal disease over time.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CHoBI7 health facility program
  • Behavioral: CHoBI7 mHealth program
  • Behavioral: CHoBI7 home visit program
N/A

Detailed Description

The findings from the recent randomized controlled trial of The Cholera Hospital Based Intervention for 7 Days (CHoBI7) demonstrated that this intervention was effective in significantly reducing symptomatic cholera infections in intervention households, and had significant sustained impacts on hand washing with soap behaviors and improved water quality 12 months post intervention. Next steps to transition to scale were: (1) Develop and evaluate scalable approaches to integrate the CHoBI7 intervention into the services provided for hospitalized diarrhea patients at health facilities in Bangladesh; and (2) Evaluate the ability of the CHoBI7 intervention to lead to a sustained uptake of the promoted hand washing with soap and water treatment behaviors and significant reductions in diarrheal disease over time.

Study Design

Study Type:
Interventional
Actual Enrollment :
2626 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Masking Description:
Masking was not possible because the intervention included visible components including a handwashing station and a covered drinking water storage vessel.
Primary Purpose:
Prevention
Official Title:
CHoBI7 Trial: A Hospital Based Water, Sanitation and Hygiene Intervention for Households of Diarrheal Patients in Bangladesh
Actual Study Start Date :
Dec 4, 2016
Actual Primary Completion Date :
Apr 26, 2019
Actual Study Completion Date :
Apr 26, 2019

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Standard recommendation (ORS)

Participants received the standard recommendation on oral rehydration solution use

Experimental: mHealth with no home visits

Participants received the health facility delivery of CHoBI7, plus bi-weekly mHealth (voice and text) reminders for 12 months

Behavioral: CHoBI7 health facility program
The CHoBI7 health facility program focuses on promoting handwashing with soap and water treatment to diarrhea patients and their household members during the one-week period after the patient is admitted to the health facility, when their household is at highest risk for diarrheal diseases. The CHoBI7 program includes: (1) a WASH pictorial module delivered by a health worker bedside to diarrhea patient and their household members in a health facility on handwashing with soap, water treatment, and safe water storage; and (2) a diarrhea prevention package containing chlorine tablets for water treatment, a soapy water bottle (water and detergent powder), a handwashing station, and a water vessel with a lid and tap for safe drinking water storage. Households are instructed to boil their water once their supply of chlorine tablets is completed.

Behavioral: CHoBI7 mHealth program
The CHoBI7 mHealth (mobile health) program targets five key behaviors: (1) preparing soapy water using water and detergent powder; (2) handwashing with soap at food and stool related events; (3) treating household drinking water using chlorine tablets during the one week high risk period after the diarrhea patient in the household was admitted to the health facility; (4) safe drinking water storage in a water vessel with a lid and tap; and (5) heating of household drinking water until it reaches a rolling boil after the one week high risk period. Participant households receive bi-weekly voice and text messages from the CHoBI7 mHealth program over a 12-month period. These mobile messages are sent using the VIAMO platform (www.viamo.io).

Experimental: mHealth with home visits

Participants received the health facility delivery of CHoBI7, plus two home visits and bi-weekly mHealth (voice and text) reminders for 12 months

Behavioral: CHoBI7 health facility program
The CHoBI7 health facility program focuses on promoting handwashing with soap and water treatment to diarrhea patients and their household members during the one-week period after the patient is admitted to the health facility, when their household is at highest risk for diarrheal diseases. The CHoBI7 program includes: (1) a WASH pictorial module delivered by a health worker bedside to diarrhea patient and their household members in a health facility on handwashing with soap, water treatment, and safe water storage; and (2) a diarrhea prevention package containing chlorine tablets for water treatment, a soapy water bottle (water and detergent powder), a handwashing station, and a water vessel with a lid and tap for safe drinking water storage. Households are instructed to boil their water once their supply of chlorine tablets is completed.

Behavioral: CHoBI7 mHealth program
The CHoBI7 mHealth (mobile health) program targets five key behaviors: (1) preparing soapy water using water and detergent powder; (2) handwashing with soap at food and stool related events; (3) treating household drinking water using chlorine tablets during the one week high risk period after the diarrhea patient in the household was admitted to the health facility; (4) safe drinking water storage in a water vessel with a lid and tap; and (5) heating of household drinking water until it reaches a rolling boil after the one week high risk period. Participant households receive bi-weekly voice and text messages from the CHoBI7 mHealth program over a 12-month period. These mobile messages are sent using the VIAMO platform (www.viamo.io).

Behavioral: CHoBI7 home visit program
The CHoBI7 home visit program involves two, 30-minute home visits conducted during the week after the index diarrhea patient was recruited at the health facility. A health worker reinforces the content of the CHoBI7 health facility program in the participant's home.

Outcome Measures

Primary Outcome Measures

  1. Diarrhea prevalence among children under 2 years of age [12 months]

    Diarrhea prevalence among children under 2 years of age assessed by caregiver self report over a 12-month period

  2. Diarrhea prevalence among children under 5 years of age [12 months]

    Diarrhea prevalence among children under 5 years of age assessed by caregiver self report over a 12-month period

  3. Diarrhea prevalence among all household members [12 months]

    Diarrhea prevalence among all household members assessed by self report over a 12-month period

Secondary Outcome Measures

  1. Diarrhea prevalence among participants ages 5-9 years [12 months]

    Diarrhea prevalence among all household members ages 5-9 years assessed by self report over a 12-month period

  2. Diarrhea prevalence among participants ages 10-18 years [12 months]

    Diarrhea prevalence among all household members ages 10-18 years assessed by self report over a 12-month period

  3. Diarrhea prevalence among participants ages greater than 18 years [12 months]

    Diarrhea prevalence among all household members ages greater than 18 years assessed by self report over a 12-month period

  4. Handwashing with soap [12 months]

    Household members handwashing with soap at food and stool related events assessed by 5-hour structured observation over a 12-month period

  5. Household drinking water treatment [12 months]

    Households with stored drinking water samples without detectable E.coli (<1 colony forming units / 100 ml) assessed by unannounced household visits for sample collection of household stored drinking water over a 12-month period

  6. Height-for-age among children under 2 years of age [12 months]

    Height, weight and age measurements among children under 2 years of age assessed over a 12-month period were used to calculate height-for-age z-scores according to the World Health Organization child growth standards

  7. Height-for-age among children under 5 years of age [12 months]

    Height, weight and age measurements among children under 5 years of age assessed over a 12-month period were used to calculate height-for-age z-scores according to the World Health Organization child growth standards

  8. Weight-for-age among children under 2 years of age [12 months]

    Height, weight and age measurements among children under 2 years of age assessed over a 12-month period were used to calculate weight-for-age z-scores according to the World Health Organization child growth standards

  9. Weight-for-age among children under 5 years of age [12 months]

    Height, weight and age measurements among children under 5 years of age assessed over a 12-month period were used to calculate weight-for-age z-scores according to the World Health Organization child growth standards

  10. Weight-for-height among children under 2 years of age [12 months]

    Height, weight and age measurements among children under 2 years of age assessed over a 12-month period were used to calculate weight-for-height z-scores according to the World Health Organization child growth standards

  11. Weight-for-height among children under 5 years of age [12 months]

    Height, weight and age measurements among children under 5 years of age assessed over a 12-month period were used to calculate weight-for-height z-scores according to the World Health Organization child growth standards

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Diarrhea patients will be defined as patients having acute watery diarrhea three or more loose stools over a 24-hour period in the past three days. Diarrhea patients admitted to

ICDDRB Dhaka Hospital or Mugda General Hospital will be eligible for the trial if:
  1. have had 3 or more loose stools over the past 24 hours

  2. plan to reside in Dhaka for the next 12 months

  3. have no basin for running water in their home

  4. have a child under five years of age in their household (including themselves) that produced a stool sample at baseline

  5. have a working mobile phone in the household.

Household members of the diarrhea patient will be eligible for the trial if:
  1. they have shared the same cooking pot and resided in the same home with the diarrhea patient for the last three days

  2. plan to reside in their current household with the diarrhea patient for the next 12 months

Exclusion Criteria:

(1) Children in foster care will be excluded from all research study activities.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Johns Hopkins Bloomberg School of Public Health
  • International Centre for Diarrhoeal Disease Research, Bangladesh

Investigators

  • Principal Investigator: Christine Marie George, PhD, Johns Hopkins Bloomberg School of Public Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Johns Hopkins Bloomberg School of Public Health
ClinicalTrials.gov Identifier:
NCT04008134
Other Study ID Numbers:
  • IRB00006785
  • PR-15133
First Posted:
Jul 5, 2019
Last Update Posted:
Feb 10, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Johns Hopkins Bloomberg School of Public Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2022